Cancer Research UK : UK Bladder Cancer incidence statistics

UK Bladder Cancer incidence statistics

This page presents bladder cancer incidence statistics including incidence by age and sex, socio-economic deprivation, geographical variation and trends over time and histology. The ICD code for bladder cancer is ICD9 188, ICD10 C67.

Bladder cancer is a common cancer in the UK, with 10,278 new cases in 2005.1-4 It is the most frequently occurring tumour of the urinary system and accounts for 1 in every 28 new cases of cancer each year in the UK.

Bladder cancer is more common in men than women, with a worldwide male:female ratio of 10:3.5

Bladder cancer incidence by age and sex

In the UK bladder cancer is the fourth most common cancer in males, with 7,310 new cases diagnosed in 2005.1-4 This compares to 2,968 female cases, giving a male:female ratio of 5:2. In females it is the tenth most common cancer.

The numbers and rates for the UK and its constituent countries are shown in Table 1.1.1-4

Table showing the number of new cases and rates of bladder cancer in the UK

Download this table (33KB)

Few cases occur under the age of 50, but thereafter the rates rise with age to reach a peak in the oldest age-groups when rates in elderly men are more than three times higher than in elderly women (Figure 1.1).1-4

Chart showing the number of new cases of bladder cancer in the UK

Download this chart (37KB)

Bladder cancer incidence by socio-economic deprivation

British data show only a small deprivation gradient, with the lowest bladder cancer rates recorded for the most affluent and the highest for the most deprived groups.7,8

Geographic variation in bladder cancer incidence

An analysis of cancer incidence in the UK and Ireland highlighted considerable differences between cancer registries in the classification of bladder tumours which make the interpretation of any geographical patterns difficult.6 These differences in registration practice will also limit international comparisons.

The 2002 estimated age-standardised bladder cancer incidence rates reported for UK men are well below the EU average (25.3 v 34.4 per 100,000 population respectively) and the rate for women in the UK is slightly higher than (7.9 v 7.0 per 100,000 population respectively) as Figure 1.2 shows. More recent age-standardised rates for the UK show a further drop - 19.8 for men and 5.9 for women (see Figure 1.5 below).

Chart showing the age-standardised incidence rates for bladder cancer, by sex, for the European Union, 2002 estimates

Download this chart(47KB)

Worldwide an estimated 356,600 new cases of bladder cancer occur each year and, in terms of overall cancer frequency, it is ranked as ninth.5 World incidence rates for bladder cancer show comparatively low variation (Figure 1.3) compared to other cancers.9

Chart showing the age-standardised incidence rates for bladder cancer, by sex, for the world regions, 2002

Download this chart (42KB)

The highest bladder cancer incidence rates are generally found in industrially developed countries, particularly in North America and Western Europe, and in areas associated with endemic schistosomiasis in Africa and the Middle East. Egypt has the highest reported rates (37 per 100,000 population) in the world due to endemic schistosomiasis. Very low rates (< 5 per 100,000 population) are reported for India and China.

Marked racial differences have been reported for bladder cancer incidence with higher rates in white than non-white populations. For example, in the USA, rates for white men are double those for black men: in 2000-2003 the age-adjusted incidence rate per 100,000 population was 40.2 for white males compared to 19.8 in black Americans. Bladder risk for US black women is about two-thirds that of US white women.10

These differences may be partly due to genes, as studies have shown that certain genetic polymorphisms linked to an increased risk of bladder cancer (for example, the NAT2 slow acetylator polymorphism) are much more prevalent in white than non-white populations11 – see Molecular Biology and Genetics section for more details.

Bladder cancer incidence trends

Time trends in bladder cancer incidence rates are difficult to interpret because of different and changing classification/coding practices affecting the definition of invasive carcinoma of the bladder.

In Great Britain, the age-standardised incidence rates per 100,000 population rose throughout the 1970s and 1980s to reach a peak of 31 in men and 9 in women in the early 1990s and since then have fallen by a third. (Figure 1.4).12

Chart showing the age-standardised incidence rates for bladder cancer in Great Britain

Download this chart (45KB)

UK bladder cancer incidence trends are shown in Figure 1.5

Figure showing age-standardised (European) incidence rates of bladder cancer, by sex, in the UK

Download this chart (40KB)

The age-specific bladder cancer incidence rates in Great Britain Figure 1.6 and Figure 1.7 show a consistent decrease since the early 1990s for all age-groups under age 85.12 Some of this decrease is likely to be due coding changes but reductions in smoking and exposure to occupational carcinogens may also have played a role, especially as the mortality rates have also decreased.13

Figure showing age-specific incidence rates of bladder cancer for males in Great Britain

Download this chart (37KB)

Figure showing age-specific incidence rates of bladder cancer for females in Great Britain

Download this chart (38KB)

Bladder cancer histology

In developed countries around 90% of bladder cancers are transitional cell carcinomas while the remaining 10% are squamous cell carcinomas and adenocarcinomas. Benign transitional cell papillomas have sometimes and in some places been registered as invasive carcinomas. This variation in registration practice has to be taken into account when comparing incidence and survival rates over time and place.6

Where the bladder cancer is associated with chronic bladder infection, most commonly with waterborne parasitic flatworms called schistosomes, the usual histology is squamous cell carcinoma. Schistosomiasis-associated bladder cancer has an earlier mean age at onset, typically in the fifth decade of life, and tends to present at a later stage than transitional cell carcinomas.

In countries where schistosomiasis (also called bilharzia ) is endemic, such as Egypt, bladder cancer is the most common cancer in men.5 Prevention of infection in these countries is paramount.7 Subsequent information in this section concerns bladder cancer in the UK and other developed countries unless otherwise specified.

References for bladder cancer incidence

Office for National Statistics, Cancer Statistics registrations: registrations of cancer diagnosed in 2005, England. Series MB1 no.35. 2008, London: National Statistics.
Welsh Cancer Intelligence and Surveillance Unit. Accessed 2008
ISD Online. Cancer incidence and mortality data. Accessed 2008
Northern Ireland Cancer Registry. Cancer statistics. Accessed 2008
IARC. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide (2002 estimates). Accessed 2005
Cooper N, C.R., Chapter 3, Bladder, in Cancer Atlas of the United Kingdom and Ireland 1991-2000, W.H. Quinn M, Cooper N, Rowan S, Editors. 2005, Palgrave Macmillan: Basingstoke, UK.
WHO, Schistosomiasis, 2006.
Quinn, M., et al., Cancer Trends in England & Wales 1950-1999. ed. Vol. SMPS No. 66. 2001: TSO.
Parkin, D.M., et al., Global cancer statistics, 2002. CA Cancer J Clin, 2005. 55(2): p. 74-108.
Ries LAG, H., Krapch M et al (eds). SEER Cancer Statistics Review, 1975-2003. Accessed 2006
Garcia-Closas, M., et al., NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 2005. 366(9486): p. 649-59.
Cancer Research UK, Statistical Information Team. Email: stats.team@cancer.org.uk.
Pelucchi, C., et al., Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol, 2006. 3(6): p. 327-40.